Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00201019 · ClinicalTrials.gov registry record · NA

Improving Adherence to Blood Pressure Guidelines

A NA study of Hypertension, sponsored by University of Iowa.

Completed
Registry status
NA
Development phase
623
Enrollment target
1
Study location

NCT00201019: Completed NA study of Hypertension, sponsored by University of Iowa.

NCT00201019 is a NA study of Hypertension that has completed, run by University of Iowa. The registered enrollment target is 623 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00201019, a NA study of Hypertension, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
NA
Development phase
623 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

Conditions Studied

Interventions

  • BEHAVIORAL Physician-pharmacist collaborative intervention

Study Locations (1)

Iowa

  • University of Iowa College of Pharmacy - Iowa City

Trial Details

FieldValue
Enrollment Target 623 participants
Start Date 2003-08
Est. Completion 2009-07
Phase NA
University of Iowa

228 total trials

What the finished NCT00201019 record still lists

NCT00201019 is an interventional study that assigns participants to a tested intervention. The registered 623 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Physician-pharmacist collaborative intervention is the first listed.

NCT00201019 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT00201019 about?

NCT00201019 is a clinical study titled "Improving Adherence to Blood Pressure Guidelines". The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

What is the current status of trial NCT00201019?

This trial is currently completed. It is a NA study. The enrollment target is 623 participants. The study started on 2003-08. Estimated completion is 2009-07.

What conditions does trial NCT00201019 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00201019?

The interventions under investigation include: Physician-pharmacist collaborative intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00201019?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00201019 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00201019's enrollment target sits among peer trials

623 100th of 470 higher than 371 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06406049 · 624 participants · NA

    Finishing HIV Project

  • NCT05349227 · 625 participants · NA

    Comprehensive Outcomes for After Cancer Health

  • NCT06103864 · 625 participants · Phase 3

    A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

  • NCT06230510 · 625 participants · NA

    Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00201019, the US trial registry maintained by the National Library of Medicine. NCT00201019 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.